Penumbra is Friday's IBD Stock Of The Day following a strong third-quarter report and a "landmark" study vs. blood thinners.

Warner Bros Discovery stock rises as Netflix unveils a $72 billion acquisition deal, transforming the future of streaming and ...

HC Wainwright upgrades Shattuck Labs on confidence in SL-325, a DR3 antibody aiming for stronger, durable IBD treatment amid TL1A concerns.

Analysts maintain a broadly bullish stance on cybersecurity giant CrowdStrike ahead of the company's third-quarter results on ...

PN-943 (IBD Program) -- Oral, gut-restricted alpha-4-beta-7 integrin antagonist demonstrated greater than threefold improved ...

• 8:00 PM ET (Monday): Fed Chair Powell Speaks - As head of the Federal Reserve, Powell’s remarks will be closely scrutinized for hints about future monetary policy direction and economic outlook.

J&J's 16.7% rise reflects stronger sales guidance, rapid pipeline advances and improving MedTech momentum amid a recovering sector.

Our research shows that rooibos tea, both fermented and unfermented, offers unique benefits for gut health. Fermented rooibos ...

Apart from immunology, AbbVie has been expanding its presence in oncology and neuroscience. In recent years, the company has ...

Following a sharp sell-off on Nov. 20, the Nasdaq composite went on a five-day win streak to celebrate Thanksgiving back above its 21-day exponential moving average and 50-day line. During that run, ...

The silver price futures contract surged to a new record on Monday, while copper and gold also shined, though not as brightly. Tight supply and expectations for more Federal Reserve rate cuts, ...